Paula Green - 14 Jun 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Signature
/s/ William Solis, as Attorney-in-Fact for Paula Green
Issuer symbol
TWST
Transactions as of
14 Jun 2021
Net transactions value
-$1,430,868
Form type
4
Filing time
16 Jun 2021, 17:21:10 UTC
Previous filing
24 May 2021
Next filing
06 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Sale $34,044 -300 -1.5% $113.48* 20,095 14 Jun 2021 Direct F1
transaction TWST Common Stock Options Exercise $40,448 +6,798 +34% $5.95 26,893 14 Jun 2021 Direct
transaction TWST Common Stock Options Exercise $20,745 +2,352 +8.7% $8.82 29,245 14 Jun 2021 Direct
transaction TWST Common Stock Options Exercise $38,798 +1,663 +5.7% $23.33 30,908 14 Jun 2021 Direct
transaction TWST Common Stock Options Exercise $81,260 +3,048 +9.9% $26.66 33,956 14 Jun 2021 Direct
transaction TWST Common Stock Sale $1,237,805 -10,921 -32% $113.34* 23,035 14 Jun 2021 Direct F2
transaction TWST Common Stock Sale $57,481 -500 -2.2% $114.96* 22,535 14 Jun 2021 Direct F3
transaction TWST Common Stock Sale $282,789 -2,440 -11% $115.90* 20,095 14 Jun 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -6,798 -38% $0.000000 11,045 14 Jun 2021 Common Stock 6,798 $5.95 Direct F5
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -2,352 -69% $0.000000 1,046 14 Jun 2021 Common Stock 2,352 $8.82 Direct F6
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -1,663 -6% $0.000000 26,137 14 Jun 2021 Common Stock 1,663 $23.33 Direct F7
transaction TWST Employee Stock Option (right to buy) Options Exercise $0 -3,048 -8.7% $0.000000 31,956 14 Jun 2021 Common Stock 3,048 $26.66 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sales price per share. The shares sold at prices ranging from $113.09 to $113.88 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $113.00 to $113.81 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $114.53 to $115.08 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 Represents the weighted average sales price per share. The shares sold at prices ranging from $115.58 to $116.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F6 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F7 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F8 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.